Clinical trial
Evaluation of the Efficacy and Safety of Hyperbaric Oxygen in Patients After Endovascular Treatment for Acute Ischemic Stroke: A Multicenter, Open-label, Randomized Controlled Clinical Trial
NCT07049692 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of Hyperbaric Oxygen in Patients After Endovascular Treatment for Acute Ischemic Stroke: A Multicenter, Open-label, Randomized Controlled Clinical Trial
- Lead sponsor
- Beijing Chao Yang Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 22, 2026
- Completion date
- March 30, 2028
- Enrollment
- 424 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke